IFNA5 anticorps (AA 121-189) (AbBy Fluor® 647)

N° du produit ABIN2176305

Cet anticorps anti-IFNA5 est un anticorps Lapin Polyclonal détectant IFNA5 dans WB, IF (cc) et IF (p). Adapté pour Humain.

Aperçu rapide pour IFNA5 anticorps (AA 121-189) (AbBy Fluor® 647) (ABIN2176305)

Antigène: IFNA5 (Interferon, alpha 5 (IFNA5))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp IFNA5 est conjugé à/à la AbBy Fluor® 647

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Détail du produit anti-IFNA5 anticorps (AbBy Fluor® 647)

Épitope: AA 121-189

Specificité: There is possible cross-reactivity with IFNA1 and IFNA6

Homologie: Human

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human IFNA5

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur IFNA5

Antigène: IFNA5 (Interferon, alpha 5 (IFNA5))

Autre désignation: Ifna5

Sujet:

Synonyms: IFN-AlphaG, INA5, INFA5, Interferon alpha-5, IFN-alpha-5, Interferon alpha-61, Interferon alpha 61, Interferon alpha G, Interferon alpha-G, interferon, alpha 5, LeIF G, IFNA5_HUMAN.

Background: Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase

ID gène: 3442

UniProt: P01569

Pathways: Signalistation JAK/STAT, Hepatitis C